HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Marketing in Brief: Coty

This article was originally published in The Rose Sheet

Executive Summary

Coty: Preferred Stock Skin Fitness men's products contain alpha hydroxy acids to "reveal younger-looking skin," the company said. Shaveburn Relief, a "clear, non-greasy" liquid, reduces the appearance of redness, Coty noted. A 2.5 fl. oz. bottle will cost $9.95. Moisture Face lotion, a daily oil-free moisturizer which "soothes shaving sting and irritation," will bow in a 6 fl. oz. bottle priced at $5.95, the company added. The company is also extending Stetson aftershave offerings with Cooling Moisture Splash, formulated with natural stone root extract for a "moisture boost," and Shaveburn Relief Soother with natural sage extract and aloe to "revitalize" and reduce the appearance of redness, according to Coty. Both are housed in 3 oz. bottles for $8.50. All four products will be on-counter September 1...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS004298

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel